Nothing Special   »   [go: up one dir, main page]

Barregard et al., 2013 - Google Patents

Human and methodological sources of variability in the measurement of urinary 8-oxo-7, 8-dihydro-2′-deoxyguanosine

Barregard et al., 2013

View HTML
Document ID
13079134425283773709
Author
Barregard L
Møller P
Henriksen T
Mistry V
Koppen G
Rossner Jr P
Sram R
Weimann A
Poulsen H
Nataf R
Andreoli R
Manini P
Marczylo T
Lam P
Evans M
Kasai H
Kawai K
Li Y
Sakai K
Singh R
Teichert F
Farmer P
Rozalski R
Gackowski D
Siomek A
Saez G
Cerda C
Broberg K
Lindh C
Hossain M
Haghdoost S
Hu C
Chao M
Wu K
Orhan H
Senduran N
Smith R
Santella R
Su Y
Cortez C
Yeh S
Olinski R
Loft S
Cooke M
Publication year
Publication venue
Antioxidants & redox signaling

External Links

Snippet

Abstract Aims: Urinary 8-oxo-7, 8-dihydro-2′-deoxyguanosine (8-oxodG) is a widely used biomarker of oxidative stress. However, variability between chromatographic and ELISA methods hampers interpretation of data, and this variability may increase should urine …
Continue reading at www.liebertpub.com (HTML) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/72—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00—Investigating or analysing materials by the use of electric, electro-chemical, or magnetic means

Similar Documents

Publication Publication Date Title
Barregard et al. Human and methodological sources of variability in the measurement of urinary 8-oxo-7, 8-dihydro-2′-deoxyguanosine
Maruvada et al. Knowledge gaps in understanding the metabolic and clinical effects of excess folates/folic acid: a summary, and perspectives, from an NIH workshop
Barragán et al. Bitter, sweet, salty, sour and umami taste perception decreases with age: Sex-specific analysis, modulation by genetic variants and taste-preference associations in 18 to 80 year-old subjects
Covaci et al. Urinary BPA measurements in children and mothers from six European member states: overall results and determinants of exposure
Linneberg et al. Effect of smoking on blood pressure and resting heart rate: a Mendelian randomization meta-analysis in the CARTA consortium
Knežević et al. Effects of aging, body mass index, plasma lipid profiles, and smoking on human plasma N-glycans
van Deventer et al. A comparison of cystatin C-and creatinine-based prediction equations for the estimation of glomerular filtration rate in black South Africans
Carpenter et al. Zinc, copper, and blood pressure: Human population studies
Akunov et al. Hemoglobin changes after long-term intermittent work at high altitude
Paprott et al. Validation of the German Diabetes Risk Score among the general adult population: findings from the German Health Interview and Examination Surveys
Slee et al. The relationship between malnutrition risk and clinical outcomes in a cohort of frail older hospital patients
Jamnik et al. Next-generation biomonitoring of the early-life chemical exposome in neonatal and infant development
Trabulsi et al. Precision of the doubly labeled water method in a large-scale application: evaluation of a streamlined-dosing protocol in the Observing Protein and Energy Nutrition (OPEN) study
Guest et al. Novel relationships between B12, folate and markers of inflammation, oxidative stress and NAD (H) levels, systemically and in the CNS of a healthy human cohort
Nierenberg et al. Blood pressure genetic risk score predicts blood pressure responses to dietary sodium and potassium: the GenSalt Study (Genetic Epidemiology Network of Salt Sensitivity)
Koene et al. Serum FGF21 levels in adult m. 3243A> G carriers: clinical implications
Confavreux et al. Lower serum osteocalcin is associated with more severe metabolic syndrome in elderly men from the MINOS cohort
Liu et al. Secondhand smoke exposure and higher blood pressure in children and adolescents participating in NHANES
Wang et al. Chinese famine exposure in infancy and metabolic syndrome in adulthood: results from the China health and retirement longitudinal study
Grau-Perez et al. Toxic metals and subclinical atherosclerosis in carotid, femoral, and coronary vascular territories: the aragon workers health study
Hanevold et al. Racial differences in microalbumin excretion in healthy adolescents
Appelhans et al. How well does the body adiposity index capture adiposity change in midlife women?: The SWAN fat patterning study
Mattern et al. Serum zinc levels and incidence of ischemic stroke: the reasons for geographic and racial differences in stroke study
Ghazizadeh et al. Reference intervals for routine biochemical markers and body mass index: A study based on healthcare center database in northeastern Iran
Taniguchi et al. Mini‐Mental State Examination score trajectories and incident disabling dementia among community‐dwelling older Japanese adults